+86-512-6515-8191（Marketing & Sales） Nantong Office: No. 888 Zhujiang Road, Juegang Street, Rudong County, Jiangsu Province Suzhou Office: Building 1, No. 188, Fuchunjiang Road, High-tech Zone, Suzhou Beijing Office: Building 2, No. 28, Yuhua Road, Airport Science and Technology Park, Shunyi District, Beijing Contact Number:+86-10-80497001
Freeze-dried Human ROS1 Fusion Gene Mutation Detection Kit (Fluorescence PCR)
20 tests/kit, 50 tests/kit
This kit is used to in vitro qualitative detection of 14 types of ROS1 fusion gene mutations in human non-small cell lung cancer samples (Table 1). The test results are for clinical reference only and should not be used as the sole basis for individualized treatment of patients. Clinicians should make comprehensive judgments on the test results based on factors such as the patient's condition, drug indications, treatment response, and other laboratory test indicators.
ROS1 is a transmembrane tyrosine kinase of the insulin receptor family. ROS1 fusion gene has been confirmed as another important non-small cell lung cancer driver gene. As a representative of a new unique molecular subtype, the incidence of ROS1 fusion gene in NSCLC About 1% to 2% [1,2]. ROS1 mainly undergoes gene rearrangement in its exons 32, 34, 35 and 36. After it is fused with genes such as CD74, EZR, SLC34A2, and SDC4, it will continue to activate the ROS1 tyrosine kinase region. Abnormally activated ROS1 kinase can activate downstream signaling pathways such as RAS/MAPK/ERK, PI3K/Akt/mTOR, and JAK3/STAT3, thereby participating in the proliferation, differentiation and metastasis of tumor cells, and causing cancer . Among ROS1 fusion mutations, CD74-ROS1 accounts for about 42%, EZR accounts for about 15%, SLC34A2 accounts for about 12%, and SDC4 accounts for about 7% . Studies have shown that the ATP-binding site of the catalytic domain of ROS1 kinase and the ATP-binding site of ALK kinase have a homology of up to 77% , so the ALK tyrosine kinase small molecule inhibitor crizotinib and so on have obvious curative effect in the treatment of NSCLC with fusion mutation of ROS1[5,6]. Therefore, detection of ROS1 fusion mutations is the premise and basis for guiding the use of crizotinib drugs. This test kit is used to guide the medication of ROS1 inhibitors and provide the basis for personalized medicine for patients with non-small cell lung cancer.
This kit uses fluorescent probe real-time PCR technology to design specific primer probes for fluorescent detection for 14 fusion mutations of the ROS1 fusion gene and the target sequence of the internal control gene. The 5' end of specific probe of 14 fusion mutations labeled FAM fluorophore as a reporter, and 5' end of specific probe of internal control labeled HEX(VIC) fluorophore as a reporter, the 3' end of specific probe labeled BHQ1 fluorophore as a quencher. When not bound to the target sequence, the fluorescent signals of the intact probes are suppressed by the quencher dye. During the PCR amplification step, hybridization of the probes to the specific single -stranded DNA template results in cleavage of the probe by the 5' to 3' exonuclease activity of the DNA polymerase resulting in separation of the reporter and quencher dyes and the generation of a fluorescent signal. With each PCR cycle, increasing amounts of cleaved probes are generated and the cumulative signal of the reporter dye increases concomitantly. Each reporter dye is measured at defined wavelengths, which enables simultaneous detection and discrimination of the amplified fusion mutations and the internal control. The qualitative detection of each mutation site in the sample is realized by 4 tubes of reaction buffer.
At the same time, the quality control of endogenous internal control is introduced as the quality control of reagents, RNA quality and the operation itself. Even if the RNA is degraded, the internal control can truly reflect the effective RNA amount in the system.
[Storage Conditions and Shelf-life]
1. Unopened kit: It should be stored at no higher than 30°C and protected from light, and the shelf-life is 12 months.
2. After opening the sealed bag, the lyophilized reagent in the tube should be used immediately.
3. RT-PCR detection should be performed immediately after reconstitution of the lyophilized reaction buffer, otherwise it should be stored below -15°C and protected from light. The validity period is 1 week, and repeated freezing and thawing should be avoided ( limited to 2 cycles).
4.After reconstituting the lyophilized positive control, it should be stored below -15°C. The validity period is 1 week, and repeated freezing and thawing should be avoided (limited to 2 cycles).
5.Transportation conditions: It can be transported stably for 1 month when the temperature is not higher than 37°C.
6. See the packaging label for the production date, production batch number and expiration date.
Applied Biosystems 7500 Real-Time PCR Systems, Applied Biosystems 7500 Fast Real-Time PCR Systems, QuantStudio® 5 Real-Time PCR Systems, SLAN ® -96P Real-Time PCR Systems(Shanghai Hongshi Medical Technology Co., Ltd. ), LightCycler® 480 Real-Time PCR system, LineGene 9600 Plus Real-Time PCR Detection System(FQD-96A，Bioer technology), MA-6000 Real-Time Quantitative Thermal Cycler (Suzhou Molarray Co., Ltd.) , BioRad CFX96 Real-Time PCR System, BioRad CFX Opus 96 Real-Time PCR System.
Suzhou Office: Building 1, No. 188, Fuchunjiang Road, High-tech Zone, Suzhou
Beijing Office: Building 2, No. 28, Yuhua Road, Airport Science and Technology Park, Shunyi District, Beijing
Contact number: +86-10-80497001
Nantong Office: No. 888 Zhujiang Road, Juegang Street, Rudong County, Jiangsu Province
Contact number: +86-513-80562882（Administration & Human Resources）